BCP Partnering Portal / Alfa Cytology
Ovarian Cancer Preclinical R&D, also known as Alfa Cytology, is a company that specializes in preclinical research solutions for ovarian cancer therapy development. The company offers a range of services, including cancer modeling, cell line development, and drug discovery. They provide various types of cancer models, such as 2D and 3D tumor models, patient-derived cell lines, and xenograft models, to support cancer research and drug development. Additionally, they offer services for target identification, drug delivery system development, and preclinical research, including efficacy evaluation, DMPK/ADME, and safety assessment. The company's goal is to support researchers and pharmaceutical companies in advancing cancer research and therapeutic development.
Alfa Cytology is a leading preclinical research service provider committed to offering specialized services and products for ovarian cancer research to pharmaceutical companies and research institutions globally. Our team of experienced scientists, bioinformaticians, and specialized oncologists collaborates to create solutions tailored to each client’s needs. We focus on understanding your unique requirements and customizing the right solution for your project.
Alfa Cytology, backed by its exceptional and dedicated scientific team, is steadfastly committed to providing specialized and comprehensive support to pharmaceutical companies and research institutes worldwide. Advanced Technology Research Expertise Customized Solutions Dedication to Excellence
2024
Where Manufacturers and Channel Partners / Distributors find each other!